Vivacitas Oncology to Present at the 2022 BIO CEO & Investor Conference
Vivacitas Oncology, Inc., a privately-held biopharmaceutical company focused on tough-to-treat cancers, will present at the upcoming 2022 BIO CEO & Investor Conference, which will be held in New York City